Navigation Links
Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
Date:7/24/2012

udy include quality-of-life assessment, sleep and motor activity scoring, as well as tolerability endpoints. 

The company is also planning a separate human abuse liability study for NKTR-181 as part of Phase 2 development for the compound. This study will measure liking scores for NKTR-181 as compared to an active opioid in approximately 20 recreational drug users.

About Opioids and Pain Management
Pain is one of the most common reasons people seek medical treatment.1 The American Pain Society estimates that 35.5 percent of the U.S. population, or 105 million people, suffer from chronic pain in the United States. Chronic pain conditions, such as osteoarthritis, back pain and cancer pain, affect at least 126 million adults in the U.S. annually and contribute to over $100 billion a year in direct healthcare expenditures and lost work time.1 Opioids are considered the most effective therapeutic option for pain, with sales exceeding over $10 billion a year in the U.S. alone.2,3 However, opioids can cause serious side effects such as respiratory depression and sedation and have the potential for addiction, abuse and misuse. In 2010, the Centers for Disease Control and Prevention reported that emergency room visits for non-medical use of opioid analgesics increased 111 percent over a five-year period.4

About Nektar
Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms.  Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for naloxegol (NKTR-118), an investigational drug candidate, which is being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation.  This agr
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
4. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. Misonix Announces New Distribution Agreement For Panama
9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)...  Zacks.com announces the list of stocks featured in the ... the latest news and events impacting stocks and the financial ... BIIB - Free Report ), Gilead (Nasdaq: GILD ... Free Report ), AbbVie (NYSE: ABBV - Free Report ... Today, Zacks is promoting its ,Buy, stock recommendations. ...
(Date:7/31/2014)... -- For the first time, cardiac surgeons, medical professionals ... SynCardia temporary Total Artificial Heart in a peer reviewed ... Journal of Visualized Experiments website. ... SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... SynCardia Total Artificial Heart," a July 18, 2014 paper ...
(Date:7/31/2014)... Ill. , July 31, 2014 ... the head of corporate and employee communications in ... Jeff Winton , senior vice president, chief ... responsible for developing and leading corporate brand initiatives ... goals across North and South America ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2
... TOKYO, November 2 Sosei Group ... today,announced that Sosei Co., Ltd., its wholly owned ... with ASKA Pharmaceuticals,Co., Ltd. ("ASKA", TSE First Section ... pill SOH-075 (NorLevo(R)). , ...
... 31 In a randomized, double-blind, placebo-controlled trial of 247 ... histological features and liver enzymes; however, vitamin E was more ... NASH is associated with fatty liver disease, insulin resistance, and ... of Americans have NASH. The disease progresses to inflammation in ...
Cached Medicine Technology:Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH-075 (NorLevo(R)) 2Vitamin E Improves NASH 2
(Date:7/31/2014)... GA (PRWEB) July 31, 2014 Developer ... camera on its Ponce City Market project in ... historic Sears, Roebuck & Company building into best-in-class office, ... completion, OxBlue reviewed Jamestown’s experience with their construction webcam ... , Jamestown wanted a construction camera ...
(Date:7/31/2014)... 2014 Leelanau Peninsula’s newest winery, Aurora ... at 7788 East Horn Road in Lake Leelanau. Joining the ... Aurora Cellars is the 25th winery along the trail. The ... wine tour events, making its trail event debut during the ... , Owners David and Faye Mathia opened the boutique winery ...
(Date:7/31/2014)... In today’s world, a good night’s sleep ... and sleep apnea (a medical problem where the airway collapses ... partners of the rest they need to face their daily ... and 20 million people in the United States alone have ... treated; and of those treated, many cannot tolerate their prescribed ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are now offering ... Systematic Review of Sexual Satisfaction . The ... Journal of Clinical and Health Psychology. , This CE ... to have accurate information about sexual satisfaction so that ... The material provides a systematic review of 197 research ...
(Date:7/31/2014)... TN (PRWEB) July 31, 2014 In many ... are required for proper storage of necessary life saving drugs. ... staff. Unfortunately there is still a high number of ambulances ... an EMT who steals the narcotics and even replaces the ... relief receives none. As seen in the case in Baraboo, ...
Breaking Medicine News(10 mins):Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:New MedixSafe Alert - Ambulances Must Have A Medical Safe, Narcotics Cabinet, or Drug Locker 2
... , March 10 Smart Balance, Inc. (Nasdaq: SMBL ) announced today that Stephen Hughes , Chairman and Chief Executive Officer of Smart Balance, ... Tuesday, March 16, 2010 . , ... , , ... ...
... technological revolution, the "light fantastic" continues to impact people,s ... and performing intricate surgery. As the golden anniversary of ... 7th, Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, ... exciting future of this amazing invention. C&EN ...
... may someday extend men,s lives, , WEDNESDAY, March 10 ... in treating late-stage prostate cancer, it often results in ... to such therapy. , Now, however, researchers working with ... the secondary tumors gain their resistance -- a finding ...
... ... investment banking and business development to LeveragePoint,s Board of Directors. , ... Cambridge, MA (PRWEB) March 10, ... Value Management software for marketing and sales, today announced that entrepreneurial advisor and seasoned ...
... ... ... , , , , ... ...
... , ... ... , , , ... ...
Cached Medicine News:Health News:Smart Balance to Present at Roth Growth Stock Conference 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:Peyton Marshall Joins LeveragePoint Innovations Board 2Health News:Peyton Marshall Joins LeveragePoint Innovations Board 3Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 2Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 3Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 4Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 5Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 6Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 2Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 3Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 4Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 5
The Aaron 900 high frequency desiccator forever removes the need to go through a tedious multi-step process to change from low to high power....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
Medicine Products: